Pfizer and the UK cancer landscape: the pharmaphorum podcast
Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK cancer landscape.
The pharma company’s UK oncology medical director, she brought a well-informed perspective to issues such as the impact of the NHS Long Term Plan and the UK health service’s pressure points.
Also discussed were some of the challenges for patient access to medicines in the UK, with a focus on new, innovative treatments, and whether the new VPAS scheme will improve the situation.
The episode is rounded out with a look at some of Pfizer’s collaborative work in oncology in the UK and how it seeks to work with healthcare professionals and the NHS.